Investment Firm
Overview
George Medicines is a drug manufacturing company that improves the management of non-communicable diseases.
Jul 20, 2022
Series Unknown
Highlights
Location
Social
Investor Lead
Participant Investors
2
Investor Name |
---|
Brandon BioCatalyst |
Brandon Capital |
George Medicines raised $1032594 on 2022-07-20 in Venture Round
George Medicines is a drug manufacturing company that improves the management of non-communicable diseases.
Company Funding History
2
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Mar 09, 2020 | Venture Round - George Medicines | 3 | - | 35.3M |
Jul 20, 2022 | Venture Round - George Medicines | 2 | - | 1.0M |
Recent Activity
News
Jul 20, 2022
George Medicines - Triple combination candidate GMRx4 advances into Phase II clinical development for first-line treatment of type 2 diabetes
News
Jul 20, 2022
Yahoo Finance - George Medicines advances triple combination candidate GMRx4 into Phase II clinical development for first-line treatment of type 2 diabetes
News
Jul 20, 2022
Brandon Capital - Brandon Capital Portfolio George Medicines